GlassScriptPhysician profile
Letitia Cofield
NPI 1831719822
$3,137.69
in general payments reported to CMS, 2019-2025
20 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,451 · 2023: $782 · 2024: $589 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,686.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $580.40 | 2022-2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $434.47 | 2022-2023 | Nuzyra |
| Stryker Corporation | $277.93 | 2022 | |
| Axsome Therapeutics, INC. | $238.93 | 2024-2025 | Auvelity |
| Abbvie INC. | $229.43 | 2022-2024 | |
| Cardiovascular Systems INC. | $168.83 | 2023 | Diamondback Peripheral |
| Convatec INC. | $134.37 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $124.74 | 2024 | Austedo Xr |
| Integra Lifesciences Corporation | $120.29 | 2022 | |
| Lilly USA, LLC | $119.60 | 2025 | Mounjaro |
| Pacira Pharmaceuticals Incorporated | $118.46 | 2022 | |
| Grt US Holding, INC. | $116.13 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $107.62 | 2024 | Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.96 | 2022 | |
| Abbott Laboratories | $75.65 | 2025 | Freestyle Libre 3 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $73.95 | 2024 | Recorlev |
| Janssen Scientific Affairs, LLC | $48.06 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.75 | 2024 | Trintellix |
| Bioventus LLC | $23.52 | 2023 | Exogen Ultrasound Bone Healing System |
| Otsuka America Pharmaceutical, INC. | $15.60 | 2024 | Abilify Asimtufii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Letitia Cofield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.